Abiomed, Inc (ABMD)

Etorro trading 970x250
Abiomed, Inc (ABMD) Logo

About Abiomed, Inc

Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5 catheter, a percutaneous micro heart pump with integrated motor and sensors for use in interventional cardiology; and Impella CP, a device used by interventional cardiologists to support patients in the cath lab and cardiac surgeons in the heart surgery suite. It also provides Impella 5.0 and Impella LD, which are percutaneous micro heart pumps with integrated motors and sensors for use primarily in the heart surgery suite; Impella RP, a percutaneous catheter-based axial flow pump; Impella SmartAssist platform that includes optical sensor technology for improved pump positioning and the use of algorithms that enable improved native heart assessment during the weaning process; and Impella Connect, a cloud-based technology that enables secure, cloud-based, and remote viewing of the Automated Impella Controller for physicians and hospital staffs. In addition, the company engages in the development of Impella XR Sheath, a sheath designed to expand and recoil to all for ease of use upon insertion of an Impella heart pump and minimize the size of the arteriotomy; Impella BTR, a percutaneous micro heart pumps with integrated motors and sensors; and Impella ECP pump that is designed for blood flow of greater than three liters per minute. It sells its products through direct sales and clinical support personnel in the United States, Canada, Europe, and Asia. The company was founded in 1981 and is headquartered in Danvers, Massachusetts. Address: 22 Cherry Hill Drive, Danvers, MA, United States, 01923

Abiomed, Inc News and around…

Latest news about Abiomed, Inc (ABMD) common stock and company :

Abiomed (ABMD) to Report Q2 Earnings: What's in the Cards?
22 Oct, 2021 Yahoo! Finance

Continued strength in Abiomed's (ABMD) Impella product line is expected to have driven up Q2 sales.

Look Under The Hood: RXL Has 10% Upside
22 Oct, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the ProShares Ultra Health Care ETF (RXL), we found that the implied analyst target price for the ETF based upon its underlying holdings is $109.72 per unit.

Earnings Preview: Abiomed (ABMD) Q2 Earnings Expected to Decline
21 Oct, 2021 Yahoo! Finance

Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

A Legendary Money-Making Stock Rally Is Just Eight Days Away
21 Oct, 2021 FinancialContent

Ready to make some money in stocks? One of the most reliably best times for the S&P 500 is at hand — and it's just eight days away.

ABIOMED Now #404 Largest Company, Surpassing Conagra Brands
18 Oct, 2021 FinancialContent

In the latest look at the underlying components of the S&P 500 ordered by largest market capitalization, ABIOMED, Inc. (ABMD) has taken over the #404 spot from Conagra Brands Inc (CAG), according to The Online Investor..

Abiomed Second Quarter Fiscal 2022 Earnings and Conference Call Notification
07 Oct, 2021 FinancialContent

Abiomed second quarter fiscal 2022 earnings and conference call notification.

Abiomed (ABMD) Stock Jumps 5.9%: Will It Continue to Soar?
06 Oct, 2021 Yahoo! Finance

Abiomed (ABMD) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Notable Tuesday Option Activity: APPS, AOUT, ABMD
05 Oct, 2021 FinancialContent

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Digital Turbine Inc (APPS), where a total of 17,970 contracts have traded so far, representing approximately 1.8 million underlying shares. That amounts to about 51.4% of APPS's average daily trading volume over the past month of 3.5 million shares..

America’s Most Influential CEO Is Nvidia’s Jensen Huang
23 Sep, 2021 FinancialContent

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvidia CEO Jensen Huang is one of the most influential people in America. He's also one of the best CEOs. He's why you should own NVDA stock. The post America’s Most Influential CEO Is Nvidia’s Jensen Huang appeared first on InvestorPlace. More From InvestorPlace Stock Prodigy Who Found NIO at $2… Says Buy THIS Now Analyst Who Found Microsoft at $0.38 Names #1 Pick for the AI Boom America’s #1 EV Stock Still Flying Under the Radar

Analysts Anticipate 11% Gains Ahead For The Holdings of SPYG
21 Sep, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the SPDR— Portfolio S&P 500— Growth ETF (SPYG), we found that the implied analyst target price for the ETF based upon its underlying holdings is $72.88 per unit.

Here's Why You Should Retain Abiomed (ABMD) Stock For Now
20 Sep, 2021 Yahoo! Finance

Investors continue to be optimistic about Abiomed (ABMD) owing to its strength in the Impella product line.

Notable Wednesday Option Activity: EBAY, FANG, ABMD
15 Sep, 2021 FinancialContent

Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in eBay Inc. (EBAY), where a total volume of 35,198 contracts has been traded thus far today, a contract volume which is representative of approximately 3.5 million underlying shares (given that every 1 contract represents 100 underlying shares)..

2 Hot Stocks to Buy and Hold Until You Retire
15 Sep, 2021 FinancialContent

They have strong products and high financial performance.

Return Trends At Abiomed (NASDAQ:ABMD) Aren't Appealing
13 Sep, 2021 Yahoo! Finance

Did you know there are some financial metrics that can provide clues of a potential multi-bagger? Typically, we'll want...

Abiomed (ABMD) Up 6% Since Last Earnings Report: Can It Continue?
03 Sep, 2021 Yahoo! Finance

Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Abiomed Joins Rank Of Stocks With 95-Plus Composite Rating
31 Aug, 2021 FinancialContent

Abiomed saw its IBD SmartSelect Composite Rating rise to 96 Tuesday, up from 94 the day before.

Abiomed's (ABMD) Impella ECP Gets FDA's Breakthrough Device Tag
19 Aug, 2021 Yahoo! Finance

Abiomed's (ABMD) Impella ECP is likely to offer critical hemodynamic support to a wider pool of coronary artery disease patients.

Smallest Heart Pump From Abiomed Gets FDA Breakthrough Device Tag
18 Aug, 2021 FinancialContent

TheFDA has granted breakthrough device designationtoAbiomed Inc's(NASDAQ: ABMD) Impella ECP expandable ...

FDA Grants Breakthrough Device Designation to Impella ECP, the World’s Smallest Heart Pump
18 Aug, 2021 FinancialContent

The U.S. Food and Drug Administration has granted breakthrough device designation to Abiomed’s Impella ECP expandable percutaneous heart pump.

Abiomed Getting Closer To Key Technical Measure
10 Aug, 2021 FinancialContent

Abiomed shows rising price performance, earning an upgrade to its IBD Relative Strength Rating

Commit To Buy ABIOMED At $290, Earn 7.8% Annualized Using Options
09 Aug, 2021 FinancialContent

Investors considering a purchase of ABIOMED, Inc. (ABMD) shares, but tentative about paying the going market price of $346.94/share, might benefit from considering selling puts among the alternative strategies at their disposal..

ABIOMED, inc (ABMD) Q1 2022 Earnings Call Transcript
05 Aug, 2021 FinancialContent

ABMD earnings call for the period ending June 30, 2021.

Abiomed's (ABMD) Q1 Earnings and Revenues Beat, Margins Up
05 Aug, 2021 Yahoo! Finance

Abiomed's (ABMD) strength in Impella product revenues drives its Q1 top line.

Abiomed (ABMD) Beats Q1 Earnings and Revenue Estimates
04 Aug, 2021 Yahoo! Finance

Abiomed (ABMD) delivered earnings and revenue surprises of 3.77% and 3.60%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Abiomed Announces Record Revenue of $253 Million, Up 53% Year Over Year
04 Aug, 2021 FinancialContent

Abiomed announces record revenue of $253 million, up 53% year over year.

Medical Products' Aug 5 Earnings Roster: BDX, RMD & More
04 Aug, 2021 Yahoo! Finance

Let's see how Medical Product companies' stocks like BDX, RMD, CAH, ABMD and XRAY are poised ahead of their earnings releases.

Videogames entered the mainstream in the pandemic, but the industry faces a rough transition
01 Aug, 2021 FinancialContent

For decades, Wall Street has viewed videogames like most Americans: A fun little diversion from everyday life, but not something to take too seriously. But that changed during the COVID-19 pandemic.

Abiomed (ABMD) Reports Next Week: Wall Street Expects Earnings Growth
29 Jul, 2021 Yahoo! Finance

Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Abiomed (ABMD) to Report Q1 Earnings: What's in the Cards?
29 Jul, 2021 Yahoo! Finance

Continued strength in Abiomed's (ABMD) Impella product line is expected to have driven up Q1 sales.

Analysts See 11% Upside For The Holdings of RSP
20 Jul, 2021 FinancialContent

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Invesco S&P 500— Equal Weight ETF (RSP), we found that the implied analyst target price for the ETF based upon its underlying holdings is $162.34 per unit.

Abiomed, Inc (ABMD) is a NASDAQ Common Stock listed in , ,

970x250